Screener
MIRA Pharmaceuticals, Inc. MIRA Q4 2025 Annual earnings
Reported March 31, 2026 · Before market open
EPS-$0.15Miss by $0.11
EPS estimate-$0.04
Next report
Dec 2, 2026 (in 2 months)EPS estimate-$0.03
Versus estimates
Diluted EPS
Q2 2026-$0.03Q1 2026-$0.03
Q4 2025-$0.15Miss by $0.11
Q3 2025-$1.18In lineQ2 2025-$0.09Beat by $0.02Q1 2025-$0.11Beat by $0.04FAQ
- When did MIRA Pharmaceuticals, Inc. report Q4 2025 earnings?
- MIRA Pharmaceuticals, Inc. (MIRA) reported Q4 2025 earnings on March 31, 2026 before market open.
- What were MIRA Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- MIRA Pharmaceuticals, Inc. reported eps of $-0.15 for Q4 2025.
- Did MIRA Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.04 by $0.11.
- How did MIRA Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 0.0% from $-0.15.
- Where can I find MIRA Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-014001) directly on SEC EDGAR. The filing index links above go to sec.gov.
